Article Information
History
- April 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Erin K. McCreary, PharmD1,*,
- Lara Lemon, PhD PharmD2,3,
- Christina Megli, MD PhD3,
- Amber Oakes, PharmD4,
- Rachel L. Zapf, PhD5,
- Paula L. Kip, PhD RN5,
- Christopher W. Seymour, MD MSc6,7,8 and
- the UPMC Magee Monoclonal Antibody Treatment Group
- 1Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 2Clinical Analytics, UPMC, Pittsburgh, PA, USA
- 3Department of Obstetrics, Gynecology and Reproductive Sciences University of Pittsburgh School of Medicine, Pittsburgh, PA USA, Magee-Womens Research Institute, Pittsburgh PA
- 4Department of Pharmacy, Magee-Womens Hospital, UPMC, Pittsburgh, PA, USA
- 5Wolff Center, UPMC, Pittsburgh, PA, USA
- 6Office of Healthcare Innovation, UPMC, Pittsburgh, PA, USA
- 7Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 8Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- ↵*Corresponding Author
Erin K. McCreary, PharmD, BCPS, BCIDP, Clinical Assistant Professor of Medicine, University of Pittsburgh, Director of Stewardship Innovation, UPMC and Infectious Disease Connect, Falk Medical Building, Suite 5B, 3601 Fifth Avenue, Pittsburgh, PA 15213, C: 484-515-9589, E: mccrearye3{at}upmc.edu
Posted April 21, 2022.
